NephRx Corporation

About:

NephRx Corporation develops therapeutic products for acute kidney failure, renal disorders, and diseases of the gastrointestinal tract.

Website: http://nephrx.com

Description:

NephRx Corporation, a biotechnology company, engages in the discovery and development of therapeutic products for the treatment of acute kidney failure, renal disorders, and diseases of the gastrointestinal tract. It provides NX001, which is useful for the treatment of delayed graft function in kidney transplant patients; and NX002, a peptide that is derived from the naturally occurring growth factor AMP-18. The company was incorporated in 1995 and is based in Kalamazoo, Michigan.

Total Funding Amount:

$6.22M

Headquarters Location:

Kalamazoo, Michigan, United States

Founded Date:

1995-01-01

Founders:

Pratik Shah

Number of Employees:

1-10

Last Funding Date:

2010-02-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai